Cooley

Karen Tsai

Deals
4
Latest
Jun 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 4 deals
Deals by year
Karen Tsai: deals by year0123420252026 YTD: 4 M&A42026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Karen Tsai was named on, most recent first
Jun 2026 GPTZero –SuperhumanAcquisitionLegal adviser to GPTZero (target)Announced–AISuperhuman acquisition of GPTZero
May 2026 Engage Bio –Eli LillyAcquisitionLegal adviser to Engage Bio (target)Announced202.0Biotech+1Eli Lilly acquisition of Engage Bio
Apr 2026 Ajax Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Ajax Therapeutics (target)Announced2,300.0Biotech+2Eli Lilly and Company acquisition of Ajax Therapeutics
Mar 2026 Rivian Automotive –Uber TechnologiesStakeLegal adviser to Uber Technologies (acquirer)Announced300.0Automotive+1Uber Technologies stake in Rivian Automotive

Deals where Karen Tsai is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.